Stock IMV IMMUNOVACCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News ImmunoVaccine Inc. Toronto S.E.

Equities

IMV

CA45254B1031

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for ImmunoVaccine Inc.
2023 Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
2022 Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
AQ
Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
Transcript : IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
Transcript : IMV Inc. - Shareholder/Analyst Call
IMV Inc. : to Present at Two Upcoming Investor Conferences
BU
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMVIF Stock
  4. IMV Stock
  5. News ImmunoVaccine Inc.